Beneficial Effect of Upadacitinib in an Adult Patient with Juvenile Idiopathic Arthritis-associated Uveitis after Unsatisfactory Response to Tofacitinib: A Case Report.
Ocular immunology and inflammation（2022）
摘要
This case suggests that switching JAK-I might be a successful strategy in the treatment of JIAU, despite previously incomplete response to other preparations.
更多查看译文
关键词
Janus kinase inhibitors,juvenile idiopathic arthritis,therapy,upadacitinib,uveitis
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要